Our website uses cookies

Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing Filtration + Separation, you agree to our use of cookies.

Okay, I understand Learn more
Pharmaceutical & biotechnology CHANGE CATEGORY

Pharmaceutical & biotechnology news

Porvair: 2018 earnings ahead of expectations

The specialist filtration and environmental technologies group says that its 2018 earnings are forecast to be ahead of management’s expectations.

 
Sartorius appoints two new executive board members

Dr René Fáber and Gerry Mackay are to join the company’s executive board from 1 January 2019.

 

The Sanguis project has developed a process to remove ABO antibodies from donated human plasma.

 

The BDS reduces biogas temperatures.

 

GSX dust collectors exceed OSHA mandates for indoor air quality and are tested to meet NFPA and ATEX standards.

 

NX Filtration, Grundfos and Novozymes are part of an explorative collaboration.

 

The project to improve the FTA series dates back to 2015.

 

The company has added ultrafiltration to its existing range of water treatment technologies.

 

A streamlined mass flow controller.

 

For lab-scale testing with hollow fibre membranes.

 

Microfibrillated Lyocell fibres for the manufacture of high-performance filter media.

 

Seattle-based Membrion raises US$1.8 million in funding from local investors and the National Science Foundation.

 

Freudenberg Sealing Technologies, a specialist in sealing products and their application, has released its latest generation of EPDM sealing materials.

 

A call for papers to be presented to an international audience at FILTECH 2019

 

BioUrban range harnesses the power of microalgae

 

Japanese life sciences company YMC Co Ltd enters into a formal agreement to acquire Lewa-Nikkiso America Inc’s pharmaceutical systems business.

 

ISO standard best practice guide.

 

The device uses Surface Plasmon Resonance.

 

New fibre selectively eliminates certain cells

 

INDA's Hygienix 2018 conference

 
Connect with us
Most viewed in pharmaceutical & biotechnology…
News
 

The specialist filtration and environmental technologies group says that its 2018 earnings are forecast to be ahead of management’s expectations.

 
Publication
 
 
Publication
 
 
News
 

Dr René Fáber and Gerry Mackay are to join the company’s executive board from 1 January 2019.

 
Feature
 

The design and engineering of MBBR and IFAS wastewater treatment plants is full of obstacles and mistakes made can be hard to remedy.

 
What’s coming up in pharmaceutical & biotechnology…
20
Apr ’20